High glucose-induced alterations of extracellular matrix of human skin fibroblasts are not dependent on TSP-1-TGFβ1 pathway

Journal of Diabetes and its Complications

Volumn 17, Issue 6, 2003, Pages 355-364

  Yevdokimova, Natalia Yu ^a  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

Author keywords

Extracellular matrix; Fibroblasts; Glucose; TGF 1; TSP 1

Indexed keywords

CYTOKINE; FIBRONECTIN; GLUCOSE; HYALURONIC ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXPERIMENTAL DESIGN; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; STATISTICAL ANALYSIS; UPREGULATION; WESTERN BLOTTING;

EID: 0142199802     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00225-8     Document Type: Article

References (58)

1. Abdel Wahab N., Harper K., Mason R.M. Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia. Biochemical Journal. 316:1996;985-992.
2. Abdel Wahab N., Mason R.M. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture. Biochemical Journal. 320:1996;777-783.
3. Abdelouahed M., Ludlow A., Brunner G., Lawler J. Activation of platelet transforming growth factor-beta 1 in the absence of thrombospondin-1. Journal of Biological Chemistry. 275:2000;17933-17936.
4. Asselot C., Labat-Robert J., Kern P. Heparin fragments regulate collagen phenotype and fibronectin synthesis in the skin of genetically diabetic mice. Biochemical Pharmacology. 38:1989;895-899.
5. Auwerx J., Bouillon R., Collen D., Geboers I. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis. 8:1988;68-72.
6. Benazzoug Y., Borchiellini C., Labat-Robert J., Robert L., Kern P. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture. Experimental Gerontology. 33:1998;445-455.
7. Border W.A., Noble N.A. Transforming growth factor-β in tissue fibrosis. New England Journal of Medicine. 331:1994;1286-1292.
8. Cagliero E., Roth T., Roy S., Maiello M., Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. Journal of Biological Chemistry. 266:1991;14244-14250.
9. Cagliero E., Roth T., Taylor A.W., Lorenzi M. The effects of high glucose on human endothelial cell growth and gene expression are not mediated by transforming growth factor-beta. Laboratory Investigation. 73:1995;667-673.
10. Cao H.J., Hogg M.G., Martino L.J., Smith T.J. Transforming growth factor-beta induces plasminogen activator inhibitor type-1 in cultured human orbital and dermal fibroblasts. Investigative Ophthalmology and Visual Science. 36:1995;1411-1419.
11. Chajra A., Raoudi M., Delpech B., Leroy M., Basuyau J.P., Levesque H. Circulating hyaluronan and hyaluronidase are increased in diabetic rats. Diabetologia. 43:2000;387-389.
12. Chen Y.Q., Su M., Walia R.R., Hao Q., Covington J.W., Vaughan D.E. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. Journal of Biological Chemistry. 273:1998;8225-8231.
13. Crawford S., Stellmach V., Murphy-Ullrich J.E., Ribiero S.M.F., Lawler J., Hynes R.O., Boivin G.P., Bouck N. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 93:1998;1159-1170.
14. Fries K.M., Blieden T., Looney R.J., Sempowski G.D., Silvera M.R., Willis R.A., Phipps R.P. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clinical Immunology and Immunopathology. 72:1994;283-292.
15. Ginsberg L.C., Wyse B.M., Chang A. Analysis of glycosaminoglycan from diabetic and normal Chinese hamster cells. Diabetes. 30:1981;393-395.
16. Grainger D.J., Frow E.K. Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures. Biochemical Journal. 350:2000;291-298.
17. Holmes D.I.R., Abdel Wahab N., Mason R.M. Identification of glucose-regulated genes in human mesangial cells by mRNA differential display. Biochemical and Biophysical Research Communications. 238:1997;179-184.
18. Horton M.R., Olman M.A., Noble P.W. Hyaluronan fragments induce plasminogen activator inhibitor-1 and inhibit urokinase activity in mouse alveolar macrophages: a potential mechanism for impaired fibrinolytic activity in acute lung injury. Chest. 116(Suppl. 1):1999;17S.
19. Huntley A.C. Cutaneous manifestations of diabetes mellitus. Dermatologia Clinica. 7:1989;531-546.
20. Jaffe E.A., Ruggiero J.T., Leung L.L.K., Doyle M.J., McKeown-Longo P.J., Mosher D.F. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proceedings of the National Academy of Sciences of the United States of America. 80:1983;998-1002.
21. Kawakami T., Ihn H., Xu W., Smith E., Le Roy C., Trojanowska M. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. Journal of Investigative Dermatology. 110:1998;47-51.
22. Knott R.M., Pascal M.M., Ferguson C., Leiper J., Olson J., Muckersie E., Robertson M., Forrester J.Y. Regulation of transforming growth factor-beta, basic fibroblast growth factor and vascular endothelial growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy. Metabolism. 48:1999;1172-1178.
23. Kobayashi T., Yamasaki Y., Watanabe T. Diabetic scleroderma: a case report and biochemical analysis for glycosaminoglycans. Journal of Dermatology. 24:1997;100-103.
24. Kumano K., Schiller B., Hjelle J.T., Moran J. Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells. Blood Purification. 14:1996;165-169.
25. Mahadevan P., Larkins R.G., Fraser J.R.E., Fosang A.J., Dunlop M.E. Increase hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia. 38:1995;298-305.
26. Maiello M., Boeri D., Podesta F., Cagliero E., Vichi M., Odetti P., Adezati L., Lorenzi M. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes. 41:1992;1009-1015.
27. Marutsuka K., Woodcock-Mitchell J., Sakamoto T., Sobel B.E., Fujii S. Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes. Coronary Artery Disease. 9:1998;177-184.
28. McGregor B., Colon S., Mutin M., Chignier E., Zech P., McGregor J. Thrombospondin in human glomerulopathies: a marker of inflammation and early fibrosis. American Journal of Pathology. 144:1994;1281-1287.
29. Murphy M., Godson C., Cannon S., Kato S., Mackenzie H.S., Martin F., Brady H.R. Suppression subtractive hybridization identifies high glucose level as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. Journal of Biological Chemistry. 274:1999;5830-5834.
30. Nishimura F., Naruishi K., Yamada H., Kono T., Takashiba S., Murayama Y. High glucose suppresses cathepsin activity in periodontal-ligament-derived fibroblastic cells. Journal of Dental Research. 79:2000;1614-1617.
31. Olson B.A., Day J.R., Laping N.J. Age-related expression of renal thrombospondin 1 mRNA in F344 rats: resemblance to diabetes-induced expression in obese Zucker rats. Pharmacology. 58:1999;200-208.
32. Pascal M.M., Forrester J.V., Knott R.M. Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells. Current Eye Research. 19:1999;162-170.
33. Phan-Thanh L., Robert L., Derouette J.C., Labat-Robert J. Increased biosynthesis and processing of fibronectin in fibroblasts from diabetic mice. Proceedings of the National Academy of Sciences of the United States of America. 84:1987;1911-1915.
34. Phelan M.W., Forman L.W., Perrine S.P., Faller D.V. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. Journal of Laboratory and Clinical Medicine. 132:1998;519-529.
35. Poczatek M.H., Hugo Ch., Darley-Usmar V., Murphy-Ullrich J.E. Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1. American Journal of Pathology. 157:2000;1353-1363.
36. Raugi G., Mumby S., Abbot-Brown D., Borstein P. Thrombospondin: synthesis and secretion by cells in culture. Journal of Cell Biology. 95:1982;351-354.
37. Rennard S.I., Berg R., Martin G.R., Foidart J.M., Robey P.G. Enzyme-linked immunoassay (ELISA) for connective tissue components. Analytical Biochemistry. 104:1980;205-214.
38. Riser B.L., Ladson-Wofford S., Sharba A., Cortes P., Drake K., Guerin C.J., Yee J., Choi M.E., Segarini P.R., Narins R.G. TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. Kidney International. 56:1999;428-439.
39. Sasaki A., Naganuma H., Satoh E., Kawataki T., Amagasaki K., Nukui H. Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells. Neurologia Medico-Chirurgica (Tokyo). 41:2001;253-258.
40. Schultz-Cherry S., Chen H., Mosher D.F., Misenheimer T.M., Krutzsch H.C., Roberts D.D., Murphy-Ullrich J.E. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. Journal of Biological Chemistry. 270:1995;7304-7310.
41. Sharma K., McGowan T.A. TGF-beta in diabetic kidney disease: role of novel signaling pathways. Cytokine and Growth Factor Reviews. 11:2000;115-123.
42. Sheibani N., Sorenson Ch.M., Cornelius L.A., Frazier W.A. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in viterous and aqueous humor and is modulated by hyperglycemia. Biochemical and Biophysical Research Communication. 267:2000;257-261.
43. Shindo H., Thomas T., Larkin D.D., Karhaloo A., Inada H., Onaya T., Stevens M., Greene D. Modulation of basal nitric oxide-dependent cyclic-cGMP production by ambient glucose, myoinositol, and protein kinase C in SH-SY5Y human neuroblastoma cells. Journal of Clinical Investigation. 97:1996;736-745.
44. Skehan Ph., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. New colorimetric cytotoxicity assay for anticancer-drug screening. Journal of the National Cancer Institute. 82:1990;1107-1112.
45. Sternberg M., Cohen-Forterre L., Peyroux J. Connective tissue in diabetes mellitus: biochemical alterations of the intercellular matrix with special reference to proteoglycans, collagens and basement membranes. Diabete Metabolisme. 11:1985;27-50.
46. Tada H., Isogai S. The fibronectin production is increased by thrombospondin via activation of TGFbeta in cultured human mesangial cells. Nephron. 79:1998;38-43.
47. Tada H., Tsukamoto M., Nakayama K., Isogai S. The changes of glomerular thrombospondin in STZ-diabetic rats and the effect of high glucose on the synthesis of it in cultured mesangial cells. abstract Diabetes. 41:1992;122. (Suppl.).
48. Takeda M., Babazono T., Nitta K., Iwamoto Y. High glucose stimulates hyaluronan production by renal interstitial fibroblasts through the protein kinase C and transforming growth factor-beta cascade. Metabolism. 50:2001;789-794.
49. Tiedemann K., Malmstrom A., Westergren-Thorsson G. Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. Matrix Biology. 15:1997;469-478.
50. Twigg S.M., Joly A.H., Chen M.M., Tsubaki J., Kim H.S., Hwa V., Oh Y., Rosenfeld R.G. Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology. 143:2002;1260-1269.
51. Varga J., Rosenbloom J., Jimenez S.A. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochemical Journal. 247:1987;597-604.
52. Wang S., Shiva S., Poczatek M.H., Darley-Usmar V., Murphy-Ulrich E. Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-β activation in mesangial cells. Journal of Biological Chemistry. 277:2002;9880-9888.
53. Wrana J.L., Overall C.M., Sodek J. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. European Journal of Biochemistry. 197:1991;287-519.
54. Yevdokimova N., Wahab N., Mason R.M. Thrombospondin-1 is the key activator of TGF-β1 in human mesangial cells exposed to high glucose. Journal of the American Society of Nephrology. 12:2001;703-712.
55. Yevdokimova N., Freshney R.I. Activation of paracrine growth factors by heparan sulphate induced by glucocorticoid in A549 lung carcinoma cells. British Journal of Cancer. 76:1997;281-289.
56. Yevdokimova N., Yefimov A. High glucose does not increase insulin-stimulated heparan sulphate synthesis in IDDM dermal fibroblasts. Diabetologia Croatica. 29:2000;67-76.
57. Yevdokimova N., Yefimov A. Effects of wheat germ agglutinin and concavalin A on the accumulation of glycosaminoglycans in pericellular matrix of human dermal fibroblasts. A comparison with insulin. Acta Biochimica Polonica. 48:2001;563-572.
58. Zozulinska D., Derc K., Majchrzak A., Szczepanik A., Wierusz-Wysocka B. Assessment of plasma fibronectin concentration in type 1 diabetic patients. Polskie Archiwum Medycyny Wewnetrznej. 102:1999;773-777.